Legal Representation
Attorney
Peter J. Willsey
USPTO Deadlines
Next Deadline
906 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220802)
Due Date
August 02, 2028
Grace Period Ends
February 02, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 2, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 2, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 1, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 30, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 28, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 27, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 27, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 21, 2022 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Mar 14, 2022 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Mar 10, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 8, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 11, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 7, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 11, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 15, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 13, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 13, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 13, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 19, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 15, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 15, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 15, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 11, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 23, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 23, 2020 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 23, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 23, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 16, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 16, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 27, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 14, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 13, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 27, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 27, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical devices providing RF and electromagnetic treatments within the sino-nasal cavities; Medical device for use in the sino-nasal cavities to treat chronic rhinitis and inflammatory conditions; surgical and medical apparatus and instruments for use in examination, treatment, and surgery of the sino-nasal cavities
First Use Anywhere:
20210200
First Use in Commerce:
20210200
Classification
International Classes
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THE RHINITIS NEUROLYSIS THERAPY"